Upadacitinib Effective Against Nonradiographic AxSpA
The JAK inhibitor was effective and safe for patients with rheumatologist-diagnosed axial spondyloarthritis that did not meet radiographic criteria.
Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The JAK inhibitor was effective and safe for patients with rheumatologist-diagnosed axial spondyloarthritis that did not meet radiographic criteria.
A new study provides definitive proof of one pathway that contributes to lupus, though it’s unclear how many patients with lupus are affected by this mechanism.
Response to arthritis treatment can now be predicted by genes, thereby paving the way for future drug development.
Shielding status was the highest ranked of all the risk factors identified for early mortality from COVID-19.
Nearly all participants in the study showed complete seroconversion, in contrast to similar studies in adults.